Remdesivir and standard care vs placebo or usual care
In‐hospital mortality at up to day 150 · hospitalised individuals with COVID‐19 (moderate to severe disease)
Remdesivir and standard care showed no clear difference in in‐hospital mortality at up to day 150 compared with standard care (plus/minus placebo) (moderate certainty).
1 finding from 1 review
- RR 0.93 [0.84, 1.03]1 study · 8275 participantsModerate